Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

REFRACTEC MCS-100

K-Number: K980522 · 1998-07-22

Decision Date1998-07-22
Product CodeHQR
Advisory CommitteeOP
DecisionUnknown

Device Summary

REFRACTEC MCS-100 is the device name listed in this FDA 510(k) record. The listed applicant is Refractec, Inc.. It received FDA 510(k) clearance on 1998-07-22 under 510(k) number K980522. The device is classified under product code HQR. It was reviewed by the OP advisory panel. FDA Decision: Unknown.

Frequently Asked Questions

What is the REFRACTEC MCS-100?

REFRACTEC MCS-100 is a medical device that received FDA 510(k) clearance on 1998-07-22. The listed applicant is Refractec, Inc.. The 510(k) number is K980522.

When did REFRACTEC MCS-100 receive FDA 510(k) clearance?

REFRACTEC MCS-100 received FDA 510(k) clearance on 1998-07-22, under 510(k) number K980522.

Who is the listed applicant for REFRACTEC MCS-100?

The FDA 510(k) record lists Refractec, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for REFRACTEC MCS-100?

The FDA product code for REFRACTEC MCS-100 is HQR.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Refractec, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: HQR)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑